BSXBoston Scientific Corporation

$103B

FY 2016 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8.4B+12.2% YoY

Gross Profit

$5.3B63.7% margin

Operating Income

$1.2B14.7% margin

Net Income

$347M4.1% margin

EPS (Diluted)

$0.25

Cash Flow

Operating Cash Flow

$972M

Free Cash Flow

$596M

Stock-Based Comp.

$116M

Balance Sheet

Total Assets

$18.1B

Total Liabilities

$11.4B

Stockholders' Equity

$6.7B

Cash & Equivalents

$196M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8.4B	$7.5B	+12.2%
Gross Profit	$5.3B	$4.6B	+17.1%
Operating Income	$1.2B	$790M	+56.5%
Net Income	$347M	-$239M	+245.2%

BSX FY 2016 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena